New research suggests that genetic variation predicts response to cognitive behavior therapy (CBT) for the treatment of pediatric anxiety. We discuss this intriguing finding, review its implications for understanding the etiology of psychopathology, and suggest that psychosocial treatment research would strongly benefit from routinely assessing genetic variation in clinical trials.
Copyright © 2011 Elsevier Ltd. All rights reserved.